No Data
No Data
Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
Cocrystal Pharma Approves 2025 Equity Incentive Plan
COCRYSTAL PHARMA Earnings Preview: Recent $COCP Insider Trading, Hedge Fund Activity, and More
Cocrystal Pharma (COCP) Gets a Buy From Noble Financial
Cocrystal Pharma | 10-K: FY2024 Annual Report
Cocrystal Pharma Reported Unrestricted Cash as of Dec 31 of $9.9M >COCP